Skip to main content
Erschienen in: Journal of Cancer Education 3/2016

27.10.2015

Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs

verfasst von: Siu-kuen Azor Hui, Suzanne M. Miller, Leah Hazuda, Kimberly Engelman, Edward F. Ellerbeck

Erschienen in: Journal of Cancer Education | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Participation in cancer prevention trials (CPT) is lower than 3 % among high-risk healthy individuals, and racial/ethnic minorities are the most under-represented. Novel recruitment strategies are therefore needed. Online health risk assessment (HRA) serves as a gateway component of nearly all employee wellness programs (EWPs) and may be a missed opportunity. This study aimed to explore employees’ interest, willingness, motivators, and barriers of releasing their HRA responses to an external secure research database for recruitment purpose. We used qualitative research methods (focus group and individual interviews) to examine employees’ interest and willingness in releasing their online HRA responses to an external, secure database to register as potential CPT participants. Fifteen structured interviews (40 % of study participants were of racial/ethnic minority) were conducted, and responses reached saturation after four interviews. All employees showed interest and willingness to release their online HRA responses to register as a potential CPT participant. Content analyses revealed that 91 % of participants were motivated to do so, and the major motivators were to (1) obtain help in finding personally relevant prevention trials, (2) help people they know who are affected by cancer, and/or (3) increase knowledge about CPT. A subset of participants (45 %) expressed barriers of releasing their HRA responses due to concerns about credibility and security of the external database. Online HRA may be a feasible but underutilized recruitment method for cancer prevention trials. EWP-sponsored HRA shows promise for the development of a large, centralized registry of racially/ethnically representative CPT potential participants.
Literatur
2.
Zurück zum Zitat Colon-Otero G, Smallridge RC, Solberg LA Jr et al (2008) Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 112(3):447–454 Colon-Otero G, Smallridge RC, Solberg LA Jr et al (2008) Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis. Cancer 112(3):447–454
3.
Zurück zum Zitat Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726CrossRefPubMed Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726CrossRefPubMed
5.
Zurück zum Zitat Haynes MA, Smedley BD, Institute of Medicine (U.S.), Committee on Cancer Research among Minorities and the Medically Underserved (1999) The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. National Academy Press, Washington, D.C, xi, 338 p Haynes MA, Smedley BD, Institute of Medicine (U.S.), Committee on Cancer Research among Minorities and the Medically Underserved (1999) The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. National Academy Press, Washington, D.C, xi, 338 p
6.
Zurück zum Zitat Millon-Underwood S, Sanders E, Davis M (1993) Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs 16(1):25–33CrossRefPubMed Millon-Underwood S, Sanders E, Davis M (1993) Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs 16(1):25–33CrossRefPubMed
7.
Zurück zum Zitat Grann VR, Jacobson JS, Troxel AB et al (2005) Barriers to minority participation in breast carcinoma prevention trials. Cancer 104(2):374–379CrossRefPubMed Grann VR, Jacobson JS, Troxel AB et al (2005) Barriers to minority participation in breast carcinoma prevention trials. Cancer 104(2):374–379CrossRefPubMed
8.
Zurück zum Zitat Woods MN, Harris KJ, Mayo MS, et al (2002) Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. J Natl Med Assoc 94(7):609–618PubMedPubMedCentral Woods MN, Harris KJ, Mayo MS, et al (2002) Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. J Natl Med Assoc 94(7):609–618PubMedPubMedCentral
9.
Zurück zum Zitat Larkey LK, Ogden SL, Tenorio S et al (2008) Latino recruitment to cancer prevention/screening trials in the Southwest: setting a research agenda. Appl Nurs Res 21(1):30–39CrossRefPubMed Larkey LK, Ogden SL, Tenorio S et al (2008) Latino recruitment to cancer prevention/screening trials in the Southwest: setting a research agenda. Appl Nurs Res 21(1):30–39CrossRefPubMed
10.
Zurück zum Zitat Moinpour CM, Atkinson JO, Thomas SM et al (2000) Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 10(8 Suppl):S85–S91CrossRefPubMed Moinpour CM, Atkinson JO, Thomas SM et al (2000) Minority recruitment in the prostate cancer prevention trial. Ann Epidemiol 10(8 Suppl):S85–S91CrossRefPubMed
11.
Zurück zum Zitat Gross CP, Filardo G, Mayne ST et al (2005) The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 103(3):483–491CrossRefPubMed Gross CP, Filardo G, Mayne ST et al (2005) The impact of socioeconomic status and race on trial participation for older women with breast cancer. Cancer 103(3):483–491CrossRefPubMed
12.
Zurück zum Zitat Ford ME, Siminoff LA, Pickelsimer E et al (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38CrossRefPubMedPubMedCentral Ford ME, Siminoff LA, Pickelsimer E et al (2013) Unequal burden of disease, unequal participation in clinical trials: solutions from African American and Latino community members. Health Soc Work 38(1):29–38CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat American Cancer Society (2014) Cancer facts and figures 2014. Atlanta American Cancer Society (2014) Cancer facts and figures 2014. Atlanta
15.
Zurück zum Zitat Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242CrossRefPubMed
16.
Zurück zum Zitat Calderon JL, Baker RS, Fabrega H et al (2006) An ethno-medical perspective on research participation: a qualitative pilot study. Med Gen Med 8(2):23 Calderon JL, Baker RS, Fabrega H et al (2006) An ethno-medical perspective on research participation: a qualitative pilot study. Med Gen Med 8(2):23
17.
Zurück zum Zitat Byrne MM, Tannenbaum SL, Glück S et al (2014) Participation in cancer clinical trials why are patients not participating? Med Decis Mak 34(1):116–126CrossRef Byrne MM, Tannenbaum SL, Glück S et al (2014) Participation in cancer clinical trials why are patients not participating? Med Decis Mak 34(1):116–126CrossRef
18.
Zurück zum Zitat Sheppard VB, Cox LS, Kanamori MJ et al (2005) Brief report: if you build it, they will come—methods for recruiting Latinos into cancer research. J Gen Intern Med 20:444–447CrossRefPubMedPubMedCentral Sheppard VB, Cox LS, Kanamori MJ et al (2005) Brief report: if you build it, they will come—methods for recruiting Latinos into cancer research. J Gen Intern Med 20:444–447CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Corbie-Smith G, Thomas SB, Williams MV et al (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14(9):537–546 Corbie-Smith G, Thomas SB, Williams MV et al (1999) Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 14(9):537–546
20.
Zurück zum Zitat Robinson JM, Trochim WM (2007) An examination of community members’, researchers’ and health professionals’ perceptions of barriers to minority participation in medical research: an application of concept mapping. Ethn Health 12(5):521–539CrossRefPubMed Robinson JM, Trochim WM (2007) An examination of community members’, researchers’ and health professionals’ perceptions of barriers to minority participation in medical research: an application of concept mapping. Ethn Health 12(5):521–539CrossRefPubMed
21.
Zurück zum Zitat Brewster WR, Anton-Culver H, Ziogas A et al (2002) Recruitment strategies for cervical cancer prevention study. Gynecol Oncol 85(2):250–254CrossRefPubMed Brewster WR, Anton-Culver H, Ziogas A et al (2002) Recruitment strategies for cervical cancer prevention study. Gynecol Oncol 85(2):250–254CrossRefPubMed
22.
Zurück zum Zitat Schoenman JA, Chockley N (2011) Building a stronger evidence base for employee wellness programs. National Institute for Health Care Management, Washington, DC Schoenman JA, Chockley N (2011) Building a stronger evidence base for employee wellness programs. National Institute for Health Care Management, Washington, DC
23.
Zurück zum Zitat U.S. Bureau of Labor Statistics (2014) Employment status of the civilian noninstitutional population by age, sex, and race 2013 U.S. Bureau of Labor Statistics (2014) Employment status of the civilian noninstitutional population by age, sex, and race 2013
24.
Zurück zum Zitat U.S. Bureau of Labor Statistics (2013) Employment status of the Hispanic or Latino population by age and sex U.S. Bureau of Labor Statistics (2013) Employment status of the Hispanic or Latino population by age and sex
25.
Zurück zum Zitat Mattke S, Schnyer C, Van Busum KR (2012) A review of the U S workplace wellness market. Santa Monica Mattke S, Schnyer C, Van Busum KR (2012) A review of the U S workplace wellness market. Santa Monica
26.
Zurück zum Zitat Tu HT, Mayrell RC (2010) Employer wellness initiatives grow, but effectiveness varies widely. Cent Stud Health Syst Change Res Brief 1(1):1–13 Tu HT, Mayrell RC (2010) Employer wellness initiatives grow, but effectiveness varies widely. Cent Stud Health Syst Change Res Brief 1(1):1–13
27.
Zurück zum Zitat Glaser B, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago Glaser B, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago
28.
Zurück zum Zitat Boyd AD, Hosner C, Hunscher DA et al (2007) An ‘Honest Broker’ mechanism to maintain privacy for patient care and academic medical research. Int J Med Inform 76(5–6):407–411CrossRefPubMed Boyd AD, Hosner C, Hunscher DA et al (2007) An ‘Honest Broker’ mechanism to maintain privacy for patient care and academic medical research. Int J Med Inform 76(5–6):407–411CrossRefPubMed
29.
Zurück zum Zitat Boyd AD, Saxman PR, Hunscher DA et al (2009) The University of Michigan Honest Broker: a web-based service for clinical and translational research and practice. J Am Med Inform Assoc 16(6):784–791CrossRefPubMedPubMedCentral Boyd AD, Saxman PR, Hunscher DA et al (2009) The University of Michigan Honest Broker: a web-based service for clinical and translational research and practice. J Am Med Inform Assoc 16(6):784–791CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Institute of Medicine (2012) Public engagement and clinical trials: new models and disruptive technologies: workshop summary. In: Weisfeld V, English RA, and Claiborne A.B (eds.) Washington (DC), The National Academies Press Institute of Medicine (2012) Public engagement and clinical trials: new models and disruptive technologies: workshop summary. In: Weisfeld V, English RA, and Claiborne A.B (eds.) Washington (DC), The National Academies Press
31.
Zurück zum Zitat Institute of Medicine (2011) Implementing a national cancer clinical trials system for the 21st century: workshop summary. In: Mack A, and Nass S.J (ed.) Washington, DC, The National Academies Press 100 Institute of Medicine (2011) Implementing a national cancer clinical trials system for the 21st century: workshop summary. In: Mack A, and Nass S.J (ed.) Washington, DC, The National Academies Press 100
32.
Zurück zum Zitat Institute of Medicine (2010) A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. The National Academies Press, Washington, DC, p 316 Institute of Medicine (2010) A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. The National Academies Press, Washington, DC, p 316
33.
Zurück zum Zitat Institute of Medicine (2010) Transforming clinical research in the United States: challenges and opportunities: workshop summary. The National Academies Press, Washington, DC, p 150 Institute of Medicine (2010) Transforming clinical research in the United States: challenges and opportunities: workshop summary. The National Academies Press, Washington, DC, p 150
34.
Zurück zum Zitat Porterfield D, Hinnant L, Kane H et al (2010) Linkages between clinical practices and community organizations for prevention. RTI International: Research Triangle Park, NC, pp iii–C-1 Porterfield D, Hinnant L, Kane H et al (2010) Linkages between clinical practices and community organizations for prevention. RTI International: Research Triangle Park, NC, pp iii–C-1
Metadaten
Titel
Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs
verfasst von
Siu-kuen Azor Hui
Suzanne M. Miller
Leah Hazuda
Kimberly Engelman
Edward F. Ellerbeck
Publikationsdatum
27.10.2015
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 3/2016
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-015-0927-8

Weitere Artikel der Ausgabe 3/2016

Journal of Cancer Education 3/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.